BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31293299)

  • 21. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
    Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
    Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case report of
    Zhao H; Lin C; Jiao B; Sa R; Hou S; Xu S
    Thorac Cancer; 2018 Jan; 9(1):167-170. PubMed ID: 28980762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study.
    Manohar K; Bhattacharya A; Mittal BR
    Nucl Med Commun; 2013 Jun; 34(6):540-3. PubMed ID: 23503001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the Initial Staging and Response Assessment of Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Hulikal N; Gajjala SR; Kalawat TC; Kottu R; Amancharla Yadagiri L
    Indian J Surg Oncol; 2015 Dec; 6(4):330-6. PubMed ID: 27065657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late metastatic recurrence of penile carcinoma after 10 years: Demonstration with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Sharma P
    Indian J Nucl Med; 2016; 31(3):204-6. PubMed ID: 27385892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle metastases as the initial manifestation of an unknown primary lung cancer detected on F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Agrawal K; Bhattacharya A; Singh N; Harisankar CN; Mittal BR
    Indian J Nucl Med; 2013 Jan; 28(1):34-5. PubMed ID: 24019675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herniated Urinary Bladder Detected on
    Gupta N; Verma R; Belho ES
    Indian J Nucl Med; 2020; 35(2):172-173. PubMed ID: 32351277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan Findings in a Rare Case of Subcutaneous Panniculitis-Like T-Cell Lymphoma.
    Vishnoi MG; Jain A; Sharma A; Kapoor R; Mahato A; Tiwari A
    Indian J Nucl Med; 2023; 38(1):50-52. PubMed ID: 37180181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography and Computed Tomography in the Management of Metastatic Disease from Colorectal Cancer: Results from a regional centre.
    Jafferbhoy S; Chambers A; Mander J; Paterson H
    Sultan Qaboos Univ Med J; 2015 Feb; 15(1):e52-7. PubMed ID: 25685386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer.
    Duncan JR; Carr D; Kaffenberger BH
    J Am Acad Dermatol; 2016 Jul; 75(1):186-96. PubMed ID: 26992283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.
    Mahajan S; Barker CA; Singh B; Pandit-Taskar N
    Nucl Med Commun; 2019 Jul; 40(7):744-751. PubMed ID: 31095044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
    Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M
    Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer.
    Dave SR; Samuel TA; Pucar D; Savage N; Williams HT
    Clin Nucl Med; 2015 Jan; 40(1):e63-7. PubMed ID: 25140546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare Presentation of Metastatic Endometrioid Adenocarcinoma of Uterus Mimicking as Second Primary in Urinary Bladder on
    Sharma A; Vadi SK; Sood A; Mete UK; Kakkar N; Vashishta RK; Mittal BR
    Indian J Nucl Med; 2019; 34(2):169-170. PubMed ID: 31040537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.